1. Obesity-related non-communicable diseases: South Asians vs White Caucasians;Misra;Int J Obes (Lond),2011
2. Metabolism and excretion studies in mouse after single and multiple oral doses of the 3–hydroxy–3–methylglutaryl–CoA reductase inhibitor atorvastatin.;Black;Drug Metab Dispos,1998
3. A brief review paper of the efficacy and safety of atorvastatin in early clinical trials;Bakker-Arkema;Atherosclerosis,1997
4. Short-term treatment with high-dose atorvastatin reduces LDL cholesterol but shows no anti-inflammatory effects in normolipidemic subjects with normal CRP levels;Millar;Clin Transl Sci,2010
5. Effect of lipid–lowering and anti–hypertensive drugs on plasma homocysteine levels.;Dierkes;Vasc Health Risk Manag,2007